ACADIA Pharmaceuticals
ACAD
#3456
Rank
NZ$7.47 B
Marketcap
NZ$43.65
Share price
1.36%
Change (1 day)
17.55%
Change (1 year)

Number of shares outstanding for ACADIA Pharmaceuticals (ACAD)

Number of shares outstanding as of July 2026 : 170,517,000

According to ACADIA Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 170,517,000. At the end of 2026 the company had 170,517,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for ACADIA Pharmaceuticals from 2003 to 2026

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20260.17 B0.7%
20250.16 B1.68%
20240.16 B1.05%
20230.16 B1.74%
20220.16 B0.7%
20210.16 B1.01%
20200.15 B3.09%
20190.15 B17.37%
20180.13 B6.05%
20170.12 B2.41%
20160.12 B19.76%
20150.10 B1.36%
201499.85 M11.56%
201389.5 M47.65%
201260.61 M14.81%
201152.8 M37.56%
201038.38 M2.68%
200937.38 M0.66%
200837.13 M0.52%
200736.94 M24.26%
200629.73 M27.37%
200523.34 M40.38%
200416.62 M46.32%
200311.36 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Johnson & Johnson
JNJ
2,407,216,971 1,311.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
5,691,000,000 3,237.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
893,500,000 423.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2,038,000,000 1,095.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
59,459,982-65.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
28,158,200-83.49%๐Ÿ‡บ๐Ÿ‡ธ USA